logging in or signing up Investing in Life Sciences India Flemel Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 488 Category: Science & Tech.. License: All Rights Reserved Like it (0) Dislike it (0) Added: August 06, 2007 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... Premium member Presentation Transcript Investing in Life Science in India: Investing in Life Science in India The Venture View Anula Jayasuriya, MD PhD ASSOCHAM March 28, 2006 Why Am I Here?: Why Am I Here? To 'Meet the future Nano-Bio Billionaires'! To find and fund these superstars Huge Opportunity in India Both technology Innovation in India and transfer of Technology to India Skills base Venture vs. Private Equity: Venture vs. Private Equity Stage of company: early v. expansion Level of risk: high v moderate Revenue: pre v. post Size of Investment: smaller v. larger Assessment Focus: technology v. financial VC creates the deals for PE 2005: PE and VC in LS: $217 MM in 13 deals What does LS Encompass?: What does LS Encompass? Therapeutics – novel and generic Diagnostics Devices R andamp; D Tools and Reagents Instruments Health Care Delivery – hospitals, clinics Services: CRO; Chemistry; Labs; Pharmacy What VC’s Look For: What VC’s Look For Need addressed by disruptive technology Technology backed by defendable IP Business model Valuation/Exits: IRR; 5-10x return Cost of development and time lines Competition Why VC is Important: Why VC is Important Big player in any tech boom Small co’s challenge establishment – disruption Biggest Challenges in India: Biggest Challenges in India Deal Flow Management Skills IP Business culture differences (own the task rather than the problem; control; family businesses; term sheets Exits Business Models: Business Models CRO/MFG/services – fee for service Collaborations/ JV – Risk Sharing Wholly owned Subsidiary of Ex US co Wholly Indian Company VC Value Proposition: VC Value Proposition Financing: long-term equity Business Partner: share risk and reward Networks: Access to expertise and alliances Mentoring Exit DFJ Suriya Fund: DFJ Suriya Fund LS investments in US-India corridor $ 50-$100 MM Value creation in India – beyond pure outsourcing Two partners in India; one in the US DFJ sponsorship You do not have the permission to view this presentation. In order to view it, please contact the author of the presentation.
Investing in Life Sciences India Flemel Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 488 Category: Science & Tech.. License: All Rights Reserved Like it (0) Dislike it (0) Added: August 06, 2007 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... Premium member Presentation Transcript Investing in Life Science in India: Investing in Life Science in India The Venture View Anula Jayasuriya, MD PhD ASSOCHAM March 28, 2006 Why Am I Here?: Why Am I Here? To 'Meet the future Nano-Bio Billionaires'! To find and fund these superstars Huge Opportunity in India Both technology Innovation in India and transfer of Technology to India Skills base Venture vs. Private Equity: Venture vs. Private Equity Stage of company: early v. expansion Level of risk: high v moderate Revenue: pre v. post Size of Investment: smaller v. larger Assessment Focus: technology v. financial VC creates the deals for PE 2005: PE and VC in LS: $217 MM in 13 deals What does LS Encompass?: What does LS Encompass? Therapeutics – novel and generic Diagnostics Devices R andamp; D Tools and Reagents Instruments Health Care Delivery – hospitals, clinics Services: CRO; Chemistry; Labs; Pharmacy What VC’s Look For: What VC’s Look For Need addressed by disruptive technology Technology backed by defendable IP Business model Valuation/Exits: IRR; 5-10x return Cost of development and time lines Competition Why VC is Important: Why VC is Important Big player in any tech boom Small co’s challenge establishment – disruption Biggest Challenges in India: Biggest Challenges in India Deal Flow Management Skills IP Business culture differences (own the task rather than the problem; control; family businesses; term sheets Exits Business Models: Business Models CRO/MFG/services – fee for service Collaborations/ JV – Risk Sharing Wholly owned Subsidiary of Ex US co Wholly Indian Company VC Value Proposition: VC Value Proposition Financing: long-term equity Business Partner: share risk and reward Networks: Access to expertise and alliances Mentoring Exit DFJ Suriya Fund: DFJ Suriya Fund LS investments in US-India corridor $ 50-$100 MM Value creation in India – beyond pure outsourcing Two partners in India; one in the US DFJ sponsorship